Phraction Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
34,535
+2,090
+6% +$1M 2.91% 7
2026
Q1
$15.9M Buy
32,445
+1,461
+5% +$793K 3.3% 8
2025
Q4
$18M Sell
30,984
-37
-0.1% -$20.9K 4.78% 6
2025
Q3
$15M Buy
31,021
+1,055
+4% +$491K 4.34% 5
2025
Q2
$12.2M Sell
29,966
-198
-0.7% -$82.8K 3.89% 7
2025
Q1
$15M Buy
30,164
+2,037
+7% +$1.1M 5.03% 3
2024
Q4
$14.6M Buy
28,127
+527
+2% +$290K 5.13% 4
2024
Q3
$17.1M Buy
27,600
+395
+1% +$234K 6.04% 3
2024
Q2
$15M Buy
27,205
+172
+0.6% +$98.5K 5.5% 4
2024
Q1
$15.7M Sell
27,033
-430
-2% -$241K 6.05% 3
2023
Q4
$14.6M Buy
27,463
+6,784
+33% +$3.28M 6.02% 4
2023
Q3
$10.5M Buy
20,679
+2,089
+11% +$1.11M 4.94% 7
2023
Q2
$9.7M Buy
18,590
+5,255
+39% +$2.84M 4.79% 7
2023
Q1
$7.69M Buy
13,335
+1,918
+17% +$1.08M 4.41% 8
2022
Q4
$6.29M Buy
11,417
+100
+0.9% +$53K 4.13% 11
2022
Q3
$5.74M Buy
11,317
+282
+3% +$158K 4.33% 8
2022
Q2
$6M Buy
11,035
+950
+9% +$523K 3.94% 7
2022
Q1
$5.96M Buy
10,085
+510
+5% +$293K 3.43% 7
2021
Q4
$6.39M Buy
+9,575
New +$5.98M 3.87% 5

Other funds holding TMO

Phraction Management's TMO Position: Q2 2026 in Review

Phraction Management increased its Thermo Fisher Scientific (TMO) stake by 6.4% in Q2 2026, buying an estimated $1M and bringing the position to 34,535 shares worth $17.3M. The position accounts for 2.91% of the portfolio, ranked #7.

Phraction Management first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $18M in Q4 2025. 504 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Phraction Management held 34,535 shares of Thermo Fisher Scientific worth $17.3M as of Q2 2026.
  • Phraction Management bought 2,090 Thermo Fisher Scientific shares in Q2 2026, an estimated $1M.
  • Thermo Fisher Scientific made up 2.91% of Phraction Management's portfolio in Q2 2026, its #7 holding.
  • Phraction Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Phraction Management's Thermo Fisher Scientific position peaked at $18M in Q4 2025.
  • 504 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Phraction Management's 13F filing for Q2 2026, filed 20 Jul 2026.